Porsch Eric A, Allas Mikel Jason, Montoya Nina R, Muñoz Vanessa L, Tan Li, Muszyński Artur, Azadi Parastoo, Hyland Stephen N, Grimes Catherine L, Kao Tzu-Ting, Lowary Todd L, St Geme Joseph W
Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada; Institute of Biological Chemistry, Academia Sinica, Nangang, Taipei, Taiwan.
J Biol Chem. 2025 Jun 6;301(7):110345. doi: 10.1016/j.jbc.2025.110345.
The emerging pediatric pathogen Kingella kingae elaborates a lipopolysaccharide (LPS) that is extended with a galactofuranose homopolymer called galactan, which is a key virulence determinant that contributes to resistance to complement-mediated and neutrophil-mediated killing. Previous work has demonstrated that the pamABCDE locus is required for galactan synthesis. In this study, mutational studies suggested that the pamC gene product is a UDP-galactofuranose (Galf) transferase and is the galactan synthase. Analysis of genome sequence data revealed two distinct pamC alleles designated pamC1 and pamC2, which correlate with the two galactan structures in K. kingae. Examination of isogenic mutants expressing either pamC1 or pamC2 demonstrated that the pamC alleles are the determinants of galactan structure. Experiments with recombinant PamC1 and PamC2 in vitro established that these proteins are galactan synthases capable of extending synthetic Galf disaccharide acceptors in the presence of UDP-Galf. Homology analysis identified critical amino acids that are essential for PamC1 and PamC2 enzymatic activity both in vitro and in K. kingae. Structural analysis of the in vitro-modified synthetic acceptors implicated PamC1 as a monofunctional enzyme capable of generating a β-(1 → 5) Galf linkage and PamC2 as a bifunctional enzyme capable of generating β-(1 → 3) and β-(1 → 6) Galf linkages. This study advances our understanding of the GT2 family of UDP-galactofuranosyltransferases.
新兴的儿科病原体金氏金杆菌产生一种脂多糖(LPS),其延伸有称为半乳聚糖的呋喃半乳糖均聚物,这是一种关键的毒力决定因素,有助于抵抗补体介导和中性粒细胞介导的杀伤。先前的研究表明,pamABCDE基因座是半乳聚糖合成所必需的。在本研究中,突变研究表明pamC基因产物是一种UDP-呋喃半乳糖(Galf)转移酶,即半乳聚糖合酶。对基因组序列数据的分析揭示了两个不同的pamC等位基因,分别命名为pamC1和pamC2,它们与金氏金杆菌中的两种半乳聚糖结构相关。对表达pamC1或pamC2的同基因突变体的检查表明,pamC等位基因是半乳聚糖结构的决定因素。在体外对重组PamC1和PamC2进行的实验确定,这些蛋白质是半乳聚糖合酶,能够在UDP-Galf存在的情况下延伸合成的Galf二糖受体。同源性分析确定了在体外和金氏金杆菌中对PamC1和PamC2酶活性至关重要的关键氨基酸。对体外修饰的合成受体的结构分析表明,PamC1是一种单功能酶,能够产生β-(1→5) Galf连接,而PamC2是一种双功能酶,能够产生β-(1→3)和β-(1→6) Galf连接。这项研究增进了我们对UDP-呋喃半乳糖基转移酶GT2家族的理解。